fbpx

Author: Fred Roeder

Dubai jobs and visas: meet the remote workers who escaped a world in lockdown

More young professionals and start-ups are choosing Dubai as their home – with newly relaxed visa rules and a fast vaccine programme among the key drivers.

The National spoke to the founder of a German homeware brand, a British software company, and a Lithuanian travel agency, along with other digital remote workers who made the move.

Several visited during the height of Europe’s winter lockdowns and have now decided to return.

“There were a lot of people who came here last autumn and stayed for several months because of the restrictions in their own countries,” said Fred Roeder, managing director of London-based Consumer Choice Centre.

“There was nowhere else to go that offered the same freedoms in Covid times.”

Now many of those visitors are making the move permanent.

“Dubai is experiencing a tectonic shift at the minute, with more and more highly skilled professionals starting to call it home,” he said.

Mr Roeder, a respected health economist, produces a regular global resilience ranking of how well countries fared in the pandemic, which last week ranked the UAE second in the world

It also recognised the Emirates for performing significantly better with its vaccination campaign than European Union countries.

The campaign, which delivers doses to people of all ages at the same time, means new arrivals can get the shots as soon as their visa residency documents are ready, which typically takes three or four weeks.

“Even though there is a lot of freedom you still see people sticking to the rules, you don’t see as many people in other countries keeping their masks on,” said Mr Roeder, a German who now too is based in Dubai.

The government’s decision to grant resident visas for working remotely make it an even more desirable location, especially for younger people.

The most recent figures available, from Dubai Tourism in late March, show 1,700 people had applied for its remote working visa – the application link is here – with most accepted. For the first time, it allows people to live in the Emirates and work for a company abroad that has no base here.

In addition, 16,000 foreign travellers opted to take advantage of the city’s free visa extension in January, Dubai Tourism’s chief executive Issam Kazim told CNN Travel. Traditional visa routes working for domestic companies, self-employment and founding a start-up business are still popular.

Originally published here.

Time for a rethink on the UAE’s red listing? An open letter to Grant Shapps, the UK’s Secretary of State for Transport

As the UAE’s coronavirus cases continue to decline, and the nation is named as one of the most covid-resilient in the world, Arabian Business is urging a rethink on the emirates’ Red List status.

Dear Mr Shapps,

It is perhaps fitting that I write to you as the Arabian Travel Market takes place in Dubai, a safe live event of global significance that I know many tourism representatives from the UK wanted to attend, but cannot.

You are of course aware of this because your Green List of safe travel destinations came into effect this week, a list that not only omits the UAE but keeps the country on your Red List.

While you will keep your counsel on this matter, the safety of the UK being your prime concern, I would urge you to reconsider this decision at the earliest opportunity (you were to review this every three weeks), and I ask this based on the following:

As the Arabian Travel Market took place in Dubai with attendees from 90 countries, on May 17 the number of new cases of coronavirus in the country fell to just 1,229, while the number of vaccine doses administered rose to 11,489,475, with a rate of 116.17 doses per 100 people.

The UAE has been consistently one of the world’s leading vaccinators and yet travel between it and the UK has been prohibited, which is to the detriment of the travel and hospitality sectors in both nations.

However, this isn’t the only reason I urge you to rethink.

On Friday, May 14, Arabian Business reported how a new report suggested the UAE is the second-most pandemic resilient country in the world. The Pandemic Resilience Index ranked 40 countries on factors including vaccination approval dates, vaccination drives, critical care bed capacity and mass testing.

The study – conducted by advocacy group Consumer Choice Centre (CCC) – aimed to provide an overview of global health system preparedness for the Covid crisis.

Israel topped the list, followed by the UAE, the US, UK and Bahrain respectively. Ukraine was last on the list of those countries, at number 41.

It is worth noting that Ukraine on May 17 had 2,136 new daily cases, nearly double the cases of the UAE, and its death toll stands at 48,184 compared to the UAE’s 1,633 (nearly 30 times fewer).

I only highlight its figures to point out that it is on the UK’s Amber List, as indeed is the USA.

Statistically, I would urge that numbers alone justify a rethink on the Red List status of the UAE.

Indeed, Fred Roeder managing director, of CCC, who led the Pandemic Resilience Index, said: “The UAE is a country that managed to quickly kick off its vaccination campaign, vaccinated over 50 percent of its population [by March 31] and has carried out extensive testing – which is why it performed so well in the index.”

Roeder continued to describe how the UAE stands out on testing and is markedly ahead of countries such as Germany, Czech Republic, Hungary, France, Lithuania and Italy.

The UAE is a country whose residents and businesses have a strong sense of respect for the coronavirus precautions put in place by the government. Our initial lock-down in 2020 was comprehensive and rigorous, with curfews in place, and permissions to be sought for leaving the home, even for grocery shopping. The UAE was among the first countries in the world to close schools, in early March of 2020.

Our vaccination take-up has been world-leading, and quite simply we do, in large part, follow the rules. There is no argument over mask wearing, here that is respected, and there are fines and measures large enough to deter non-compliance. Almost 90 percent of people surveyed saw Dubai as the safest place in the world after it re-opened, according to independent research conducted by GRS Explori, a world-leading research company for exhibitions, visitor attractions and large events and research partners of UFI, The Global Association of the Exhibition Industry.

Likewise our hospitality industry has responded in an almost heroic fashion, here hotels and restaurants are run with a world-class degree of professionalism, with operators committed to keeping customers and staff safe. They have learned lessons at every juncture of this pandemic.

And regular inspections by the authorities ensure that rules are followed at all venues, it’s that simple.

These same world-class precautions are clearly visible at our airports, with contactless check-in among the many safety features, and on board our flights, with every passenger arriving requiring a negative PCR test. Each visitor is also required to download a highly successful track and trace app.

The UAE is welcoming and deserves your attention again.

On June 7, on behalf of Arabian Business at the very least (and anyone else who chooses to add their voice to this letter) I ask you to think again and remove the UAE from the UK’s Red List.

Originally published here.

Revealed: How the UAE compares globally for pandemic resilience

The Pandemic Resilience Index ranked 40 countries on vaccination drives, critical care bed capacity and mass testing

The UAE has been listed as the second-most pandemic resilient country globally in a new report.

The Pandemic Resilience Index ranked 40 countries on factors including vaccination approval dates, vaccination drives, critical care bed capacity and mass testing.

The study – conducted by advocacy group Consumer Choice Centre (CCC) – aims to provide an overview of global health system preparedness for the Covid crisis.

Israel topped the list, followed by the UAE, the US, UK and Bahrain, respectively. Ukraine rolled in last at number 41.

The report factored in the number of Covid vaccines doses administered per 100 people as per March 31. Israel led the charge with 115.98 percent, followed by the UAE (81.1 percent) and the UK (52.53).

As of May 13, The UAE Ministry of Health and Prevention announced that the total number of doses provided stands at 11,422,565 with a rate of vaccine distribution of 115.49 doses per 100 people.

The index also factored in the number of daily tests per country. The UAE topped the league for daily Covid testing, averaging 8.29 per 1,000 people daily.

“The UAE is a country that managed to quickly kick off its vaccination campaign, vaccinated over 50 percent of its population [by March 31] and has carried out extensive testing – which is why it performed so well in the index,” said Fred Roeder, managing director, CCC.

The UAE commenced its vaccination rollout around 10 days earlier than most of the European Union but its performance has been “significantly” better, he said.

The UAE has one of the lowest numbers of hospital ICUs per capita, but with an average of over eight daily new Covid tests per thousand people, the country stands out on testing and is markedly ahead of countries such as Germany, Czech Republic, Hungary, France, Lithuania and Italy.

“The pandemic has put global health systems to an emergency test and exposed both their strengths and weaknesses,” said Roeder. “In particular, this concerns hospital capacity, planning abilities, and the existence of a regulatory system that is able to act fast and efficiently when it comes to testing and vaccination, among other things.”

The UAE maintains excellent collaborative links between its private and public health sectors, which allowed for fast execution amid a pandemic, said Roeder.

“The UAE has demonstrated that it has a smart government. Both Israel and the UAE have proved themselves to be agile countries that were quick to respond and planned the pandemic to the end,” he said, adding that the UAE offered a “role model” to European countries.

“The UAE is a forward looking country. Policy makers across the world would do well to look at the UAE’s success in tackling the Covid pandemic,” he said.

Originally published here.

The 5 Transatlantic Routes Which Will Have The Lowest Fares In The Future

Originally published here.

Switching From Smoking To Vaping Could Save Thousands Of Lives, Report Finds

Report claims over half a million Malaysians smokers would switch if vaping is promoted as a harm reduced alternative.

An international consumer group has called for a “rethink” of approaches to vaping, saying regulations that facilitate it as a means to help people quit smoking could save thousands of lives.

The Consumer Choice Center (CCC) made this call in a report it published with the World Vaping Alliance (WVA) titled “From Smoking to Vaping – Lives Saved”.

The report analysed data on smoking and vaping from 61 countries and assessed how many smokers could potentially switch to vaping if the regulations encouraged vaping as a means to quit smoking.

The researchers looked to the United Kingdom to establish a “switching rate” because of the rate at which smoking decreased while vaping increased in the UK.

In the UK, people are “actively” encouraged to switch to vaping, and the country has seen a 25% reduction in smokers since 2013 when vaping became a key asset for the UK health agencies to urge smokers to quit smoking.

In the same period, Australia, which has one of the toughest vaping regulations saw a decline in smoking of only 8%.

The report estimates that if the right regulations were in place, around 196 million smokers in the 61 countries could switch to vaping, an alternative the two organisations say is 95% less harmful than cigarettes.

In the case of Malaysia, the report cited that the country could see well over half a million smokers in this country would make the switch if vaping is promoted as a harm reduced alternative for smokers.

A growing number of studies are pointing to the effectiveness of tobacco harm reduction (THR) measures including safer alternatives to cigarettes, to help smokers kick the habit.

A recent review of studies by Public Health England, an executive agency of the UK’s Health and Social Care Department found “stronger evidence” that nicotine vaping products are effective for smoking cessation and reduction.

This was in comparison to its 2018 review of studies which found that “tens of thousands” stopped smoking as a result of vaping in 2017 alone.

In “From Smoking To Vaping – Lives Saved”, the report notes that vaping has been recognised as one of the most effective tools to help smokers quit and this has been endorsed by health authorities in several countries including the UK, France, Canada, and New Zealand.

CCC Managing Director Fred Roeder said about the report, “Smart rules on advertising e-cigarettes to smokers, displaying e-cigarettes at the point of sale for cigarettes, lower rates of taxation for e-cigarettes, and public health bodies endorsing the evidence of vaping being at least 95% less harmful than traditional smoking, everything that the UK has done right, can help save the lives of thousands of smokers by helping them switch to vaping.”

WVA Director Michael Landl meanwhile said the report highlights the significant potential of the benefits of switching from smoking to vaping.

While the benefits of vaping as an alternative to smoking have been known for some time, the research shows just how significant the potential is: almost 200 million lives saved. If COVID has shown us anything, it’s that our health is paramount and regulators that want people to quit smoking need to be led by science and ensure that ideology takes a back seat to pragmatism.

World Vapers Association (WVA) Director, Michael Land

Originally published here.

Germany’s Vaccine Drive Problems

Fred Roeder went on TalkRadio’s Mark Dolan Show to discuss the shortcomings of the German Government around the COVID19 vaccine procurement.

Originally published here.

Selbst bei einem Preis von 250 Euro je Impfung hätten wir noch Geld gespart

Die EU hat bei den Verhandlungen mit den Impfstoffherstellern die Preise gedrückt. Das dürfte sich im Nachhinein als eine fatale Fehlentscheidung erweisen. Ein Gastbeitrag.

Fred Roeder ist Gesundheitsökonom und Geschäftsführer des Consumer Choice Center, eines internationalen Verbraucherverbands mit Büros in Europa, Amerika und Asien.

Der globale Wettlauf um die Impfung aller Risikogruppen und schließlich der gesamten Weltbevölkerung gegen Covid-19 ist in vollem Gange. Einige Länder haben sehr aggressiv den Preis pro Impfung heruntergehandelt, während andere bereit waren, mehr pro Dosis zu zahlen, um schneller an die Impfstoffe zu gelangen. Wer wie die Europäische Union (EU) die Preise pro Impfstoff so sehr heruntergehandelt hat wie kaum ein anderer Staat, könnte am falschen Ende gespart haben.

Die EU zahlt lediglich halb soviel pro Dosis des AstraZeneca-Impfstoffs wie Großbritannien, und mit zwölf Euro ein Drittel weniger für den Biontech/Pfizer-Impfstoff im Vergleich zu den Briten. Israel, das wahrscheinlich das erste Land sein wird, das seine gesamte Bevölkerung durchimpft, hat etwa drei Mal soviel für den Impfstoff von Pfizer bezahlt.

Nehmen wir der Einfachheit halber an, die EU würde für alle 450 Millionen Einwohner nur den mRNA-Impfstoff des Mainzer Unternehmens Biontech verwenden. Da der Impfstoff zwei Impfungen im Abstand von 21 Tagen erfordert, müssten insgesamt 900 Millionen Dosen gekauft werden. Bei dem derzeit ausgehandelten Preis würde dies die EU (und ihre Mitgliedstaaten) 10,8 Milliarden Euro kosten.

Vorbild Israel

Bei dem höheren Preis, den Israel zu zahlen bereit ist, käme die EU auf eine Rechnung von 36 Milliarden Euro. Das scheint extrem viel Geld zu sein – ist es bei genauer Betrachtung aber nicht. Denn pro Einwohner in der EU sind das gerade einmal 80 Euro. Die Bundesregierung hat erst im Dezember knapp sechs Milliarden Euro  für eine große Schutzmaskenbestellung ausgegeben. Bei zwei Impfdosen zu jeweils 36 Euro pro Einwohner in Deutschland kommt man ebenfalls auf rund sechs Milliarden Euro. Wahrscheinlich wäre das eine bessere Investition gewesen als der Kauf von Schutzmasken.

Noch deutlicher wird die Fehlentwicklung, vergleicht man die Kosten für Impfungen mit jenen der Corona-Hilfsmaßnahmen auf EU-Ebene. Im Dezember vergangenen Jahres einigten sich die Staats- und Regierungschefs der EU darauf, zusätzlich 700 Milliarden Euro als Covid-Konjunkturprogramm in das Mehrjahresbudget der EU aufzunehmen. Das sind etwa 1500 Euro pro Einwohner und damit fast 20 Mal so viel wie man für einen schnelleren Zugang zu einem der führenden Impfstoffe hätte aufwenden müssen, wenn man bereit gewesen wäre, einen Preis pro Dosis zu zahlen wie Israel. 

Mit Stand vom 28. Februar liegt die Impfrate in der Bundesrepublik bei mageren 7,4 Impfungen pro 100 Einwohner. Das entspricht zwar dem Durchschnitt in der EU, ist dennoch nur 3,7 Prozent dessen, was nötig wäre, um die gesamte Bevölkerung zu immunisieren. Israel liegt bereits bei 93,5 Impfungen pro 100 Menschen.

Selbst wenn die EU 250 Euro pro Dosis und damit 500 Euro pro Einwohner ausgäbe, zahlte sie am Ende nur ein Drittel dessen, was für den Corona-Wiederaufbaufonds vorgesehen ist.

Falsche EU-Strategie 

Wäre es daher nicht besser, schnell auf möglichst viele Impfstoffe zuzugreifen, den Herstellern und Zulieferern einen großen Anreiz zu geben, ihre Produktionskapazitäten hochzufahren und die Bevölkerung im Rekordtempo zu immunisieren? Stattdessen konzentrieren sich die EU und ihre Mitgliedsstaaten darauf, die Pandemie fortzusetzen, auf Steuereinnahmen zu verzichten, die Lockdowns zu verlängern, die Wirtschaftstätigkeit zu lähmen und – das Tragischste – das menschliche Leid durch die Pandemie zu verlängern.

Wenn wir dereinst auf die Pandemie zurückblicken, sollten wir uns nicht wundern, wenn Länder, die einen niedrigen Preis als wichtigsten Erfolgsfaktor bei den Impfstoffverhandlungen anstrebten, am Ende eine viel höhere Rechnung serviert bekommen als die Länder, die hohe Mengen und einen schnellen Zugang zu Impfstoffen als den wichtigsten Indikator für erfolgreiche Impfstoffverhandlungen ansahen.

Originally published here.

Preparing for the next virus

The Consumer Choice Center’s Fred Roeder and Maria Chaplia report on a recent event that looked at why the EU must safeguard intellectual property rights to prepare for future pandemics.

COVID-19 took its toll on millions of people and even more are suffering from the economic consequences of the pandemic. Instead of increasing our pandemic preparedness, we are seeing more and more populist calls, both at EU and Member State level, for the erosion of intellectual property (IP) rights, jeopardising the future of innovation. COVID-19 is likely only the first of many public health crises we will encounter in the next decades, and we need to keep innovators incentivised and provide them with legislative certainty. The EU has to commit to the protection of IP rights and champion it not just at home, but globally through EU trade policy.

Policies enacted during the pandemic have predominantly come as kneejerk reactions to issues on the ground, rather than well thought out plans. As we have witnessed in the case of lockdowns and trade restrictions, acting fast without considering long-term costs can be devastating. At a global level, that also involves continuous calls for the extension of the TRIPS waiver, a clause that would allow World Trade Organization members to lift protections on certain intellectual property rights.

Rushing such decisions could imperil entire generations. Safeguarding IP rights is our only chance to make it possible for patients who will one day be diagnosed with incurable diseases, such as Alzheimer’s, Cystic Fibrosis, Diabetes, or HIV/AIDS, to ever be cured.

“There are simply not enough doses of vaccines, and the vision of the EU future should be not only green and digital, but also resilient,” Franc Bogovič MEP (SI, EPP)

European policymakers should put their pursuit of short-term approval from the voters aside and reconsider the role of intellectual property rights in preventing future pandemics and, overall, what could have been done better. This was one of the key questions of an online discussion between Franc Bogovic MEP and James Tumbridge, Common Councilman of the City of London, that we at the Consumer Choice Center hosted on 19 February.

Why a vaccine should cost 250 EUR: Penny-wise and pound foolish

Even if the EU would pay a whopping 250 EUR per dose and 500 EUR per resident, it would end up paying merely a third of what’s being earmarked for the recovery fund.

COVID-19 in Europe: Is the EU losing the vaccine race?

When it comes to Covid vaccinations, Germany stands accused of buying up extra doses, while other EU countries simply aren’t taking all the doses they’re allowed.

Is the financial muscle of Germany at play here as the country is said to be looking after its own interests at the expense of others?

The Consumer Choice Center Managing Director Fred Roeder joined the Roundtable show at TRT World to discuss #COVID19 and #vaccines in #Europe.

Scroll to top
en_USEN